New Results From The ESPRIT Trial Confirm That Dipyridamole Plus Aspirin Is The Treatment Of Choice For Preventing Recurrent Stroke

... The latest results from ESPRIT (European/Australasian Stroke Prevention in Reversible Ischaemia Trial), published in the February 2007 issue of Lancet Neurology, confirm that the combination of dipyridamole plus aspirin is the treatment of choice for secondary stroke prevention in patients with stroke of arterial origin. [click link for full article] ...